236 related articles for article (PubMed ID: 28874953)
21. Glycerophosphate-dependent peroxide production by brown fat mitochondria from newborn rats.
Drahota Z; Rauchova H; Jesina P; Vojtísková A; Houstek J
Gen Physiol Biophys; 2003 Mar; 22(1):93-102. PubMed ID: 12870704
[TBL] [Abstract][Full Text] [Related]
22. Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.
Sweeney D; Raymer ML; Lockwood TD
Biochem Pharmacol; 2003 Aug; 66(4):663-77. PubMed ID: 12906931
[TBL] [Abstract][Full Text] [Related]
23. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
Madiraju AK; Erion DM; Rahimi Y; Zhang XM; Braddock DT; Albright RA; Prigaro BJ; Wood JL; Bhanot S; MacDonald MJ; Jurczak MJ; Camporez JP; Lee HY; Cline GW; Samuel VT; Kibbey RG; Shulman GI
Nature; 2014 Jun; 510(7506):542-6. PubMed ID: 24847880
[TBL] [Abstract][Full Text] [Related]
24. Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition.
Piel S; Ehinger JK; Elmér E; Hansson MJ
Acta Physiol (Oxf); 2015 Jan; 213(1):171-80. PubMed ID: 24801139
[TBL] [Abstract][Full Text] [Related]
25. Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide.
Drahota Z; Chowdhury SK; Floryk D; Mrácek T; Wilhelm J; Rauchová H; Lenaz G; Houstek J
J Bioenerg Biomembr; 2002 Apr; 34(2):105-13. PubMed ID: 12018887
[TBL] [Abstract][Full Text] [Related]
26. [Clinical pharmacology of oral hypoglycemic drugs].
Tatoń J
Pol Tyg Lek; 1968 Sep; 23(34):1289-92. PubMed ID: 5722532
[No Abstract] [Full Text] [Related]
27. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
[TBL] [Abstract][Full Text] [Related]
28. Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.
Zhu Z; Jiang W; Thompson MD; Echeverria D; McGinley JN; Thompson HJ
Cancer Prev Res (Phila); 2015 Jun; 8(6):518-27. PubMed ID: 25804611
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of the mechanism of action of biguanides (author's transl).
Muntoni S; Tagliamonte P; Sirigu F; Corsini GU
Acta Diabetol Lat; 1973; 10(6):1300-7. PubMed ID: 4793676
[No Abstract] [Full Text] [Related]
30. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.
Owen MR; Doran E; Halestrap AP
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):607-14. PubMed ID: 10839993
[TBL] [Abstract][Full Text] [Related]
31. Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin.
Bellin C; de Wiza DH; Wiernsperger NF; Rösen P
Horm Metab Res; 2006 Nov; 38(11):732-9. PubMed ID: 17111300
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
Leverve XM; Guigas B; Detaille D; Batandier C; Koceir EA; Chauvin C; Fontaine E; Wiernsperger NF
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S88-94. PubMed ID: 14502105
[TBL] [Abstract][Full Text] [Related]
33. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway.
Morales AI; Detaille D; Prieto M; Puente A; Briones E; Arévalo M; Leverve X; López-Novoa JM; El-Mir MY
Kidney Int; 2010 May; 77(10):861-9. PubMed ID: 20164825
[TBL] [Abstract][Full Text] [Related]
34. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides.
Birsoy K; Possemato R; Lorbeer FK; Bayraktar EC; Thiru P; Yucel B; Wang T; Chen WW; Clish CB; Sabatini DM
Nature; 2014 Apr; 508(7494):108-12. PubMed ID: 24670634
[TBL] [Abstract][Full Text] [Related]
35. Coenzyme Q releases the inhibitory effect of free fatty acids on mitochondrial glycerophosphate dehydrogenase.
Rauchová H; Drahota Z; Rauch P; Fato R; Lenaz G
Acta Biochim Pol; 2003; 50(2):405-13. PubMed ID: 12833166
[TBL] [Abstract][Full Text] [Related]
36. Specific properties of heavy fraction of mitochondria from human-term placenta - glycerophosphate-dependent hydrogen peroxide production.
Honzík T; Drahota Z; Böhm M; Jesina P; Mrácek T; Paul J; Zeman J; Houstek J
Placenta; 2006; 27(4-5):348-56. PubMed ID: 15949844
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
Mehnert H
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
[No Abstract] [Full Text] [Related]
38. Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
Vigneri R; Pezzino V; Wong KY; Goldfine ID
J Clin Endocrinol Metab; 1982 Jan; 54(1):95-100. PubMed ID: 7033271
[TBL] [Abstract][Full Text] [Related]
39. Liver uptake of biguanides in rats.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of contact lens multipurpose solutions: role of oxidative stress, mitochondrial activity and P2X7 cell death receptor activation.
Dutot M; Warnet JM; Baudouin C; Rat P
Eur J Pharm Sci; 2008 Feb; 33(2):138-45. PubMed ID: 18065213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
